TGFB1 and hepatocellular carcinoma: Also, eIF3h has been found to enhance tumorigenicity, invasion, and proliferation in hepatocellular carcinoma via TGF-β and MAPK pathways, making it a prognostic marker for hepatocellular cancer patients [37].